Kennedy asks FDA to revise 'self-affirm' rule for food ingredient safety
U.S. Secretary of Health and Human Services Robert Kennedy Jr. directed the Food and Drug Administration on Monday to revise ...
Trump’s FDA nominee grilled on vaccine meeting, agency staffing
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
HHS Secretary RFK Jr. orders FDA to close food ingredients loophole
Health and Human Services Secretary Robert F. Kennedy Jr. ordered the Food and Drug Administration on Monday to revise its ...
Trump's FDA nominee faces Senate questions after agency layoffs and resignations
Dr. Marty Makary will answer questions from a Senate panel about his plans to lead the Food and Drug Administration ...
BioSpace3dOpinion
Opinion: FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...
STAT2d
Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more
Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...
Oncology Nurse Advisor3d
FDA Approves New Combined Therapy for Relapsed or Refractory DLBCL
In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo.
Plus Therapeutics soars on FDA Orphan Drug Designation for lung cancer treatment
Plus Therapeutics (PSTV) soars with FDA's Orphan Drug Designation for Rhenium Obisbemeda, targeting rare leptomeningeal metastases.
What to Know About Marty Makary, Trump’s Pick to Lead the FDA
If confirmed, Makary would run one of the nation's leading health agencies, overseeing the regulation of food and drugs.
pharmaphorum5d
Roche grabs FDA okay for would-be blockbuster eye drug faricimab
The FDA has approved Roche's much-anticipated faricimab for two major causes of blindness, setting up a market clash with Bayer and Regeneron's market leading drug Eylea. The US regulator has ...